The purpose of this flipbook is to assist healthcare workers in providing patient education around TB testing, TB infection and TB disease. Panels for patients include simple text and images to reinforce key messages and corresponding panels for providers include easy to deliver script and teaching points.
This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.
This fact sheet explains the facts about DOT.
This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.
This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.
This report describes the results of the investigation of a cluster of TB cases that occurred in Kansas from 1994 to 2000 among women with a history of working as exotic dancers and persons who were close contacts of the dancers.
This announcement gives a brief overview of World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating TB.
This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.
This manual presents a role-play-based curriculum on how to conduct a contact investigation for persons with TB. It provides scripts and evaluation forms for each role-play session.
This publication by the Treatment Action Group (TAG) and the International Community of Women Living with HIV/AIDS (ICW) provides lessons learned from two years of capacity building for HIV treatment activists. Policy makers, activists, and donors can integrate these lessons learned into their tuberculosis (TB) and TB/HIV activities advocacy work.
